Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Waldenstrom Macroglobulinemia × ublituximab × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 7 Lymphoma, Follicular 2 Optic Neuritis 1 Neuromyelitis Optica 1 Myelitis, Transverse 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Disease Progression 1

Interventions

Rituximab 44 fludarabine phosphate 24 Cyclophosphamide 22 Whole-Body Irradiation 21 Peripheral Blood Stem Cell Transplantation 19 Mycophenolic Acid 18 Cyclosporine 14 Tacrolimus 13 Dexamethasone 13 ibrutinib 11 Bortezomib 11 Calcium Dobesilate 10 Busulfan 10 Antilymphocyte Serum 9 Sirolimus 8 Etoposide 8 Methotrexate 7 Lenalidomide 7 Cyclosporins 7 Melphalan 6 Everolimus 6 idelalisib 5 Filgrastim 5 thymoglobulin 4 carfilzomib 4 Indium 4 In Situ Hybridization, Fluorescence 4 Granulocyte Colony-Stimulating Factor 4 Flow Cytometry 4 pembrolizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡